Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Taysha Gene Therapies, Inc. TSHA

Set alert

Price alert · TSHA

All alert types
4.00 USD -0.13 -3.15%

At close · Nov 2

4.00 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
3.98 × 2
Ask
3.99 × 2
3.95 Day range 4.20
3.46 52-week range 7.30
YTD
-27.27%
1 year
-19.35%
Open
4.30
Prev close
4.13
Mkt cap
1.30B
Vol
2.01M
Avg vol
3.54M
EPS
-0.41
P/E
0.00
Div yield
0.00%
More statistics
Low
3.95
High
4.20
Forward P/E
-8.65
Beta
1.31
Short ratio
10.79
Inst. own
94.28%
Dividend
0.00
Ex-div date
Earnings
Nov 3, 2026
50-d avg
4.82
200-d avg
5.32
1y target
13.00

5D chart

Chart tools
Interval
1m5m15m30m

Signals (79)
NameTimeAgo
SMA: BullishOct 30, 3:25 PM3 days ago
SMA: BearishOct 30, 3:15 PM3 days ago
SMA: BearishOct 30, 3:15 PM3 days ago
MACD: Buy SignalOct 30, 2:35 PM3 days ago
MACD: Sell SignalOct 30, 2:30 PM3 days ago
MACD: Buy SignalOct 30, 2:05 PM3 days ago
MACD: Sell SignalOct 30, 1:25 PM3 days ago
SMA: BearishOct 30, 12:45 PM3 days ago
SMA: BearishOct 30, 12:45 PM3 days ago
SMA: BullishOct 30, 12:35 PM3 days ago
SMA: BullishOct 30, 12:35 PM3 days ago
SMA: BearishOct 30, 12:30 PM3 days ago
SMA: BearishOct 30, 12:30 PM3 days ago
SMA: BullishOct 30, 12:05 PM3 days ago
SMA: BullishOct 30, 12:05 PM3 days ago
MACD: Buy SignalOct 30, 12:05 PM3 days ago
MACD: Sell SignalOct 30, 11:45 AM3 days ago
SMA: BearishOct 30, 11:10 AM3 days ago
MACD: Buy SignalOct 30, 10:45 AM3 days ago
RSI: OversoldOct 30, 10:00 AM3 days ago

Newest 20 of 79.

Financial health

Altman Z-Score

7.06 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 1

Valuation

P/E -16.2×
FY 2019: -799×FY 2020: -7.8×FY 2021: -2.5×FY 2022: -0.6×FY 2023: -1.8×FY 2024: -4.8×FY 2025: -16.2×
FY 2019 5y median -2.5× FY 2025
P/S 180×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 39.7×FY 2023: 13.3×FY 2024: 51.9×FY 2025: 180×
FY 2019 5y median 39.7× FY 2025
P/B 7.1×
FY 2019: -6593×FY 2020: 1.9×FY 2021: 4.6×FY 2022: 105×FY 2023: 2.7×FY 2024: 6.1×FY 2025: 7.1×
FY 2019 5y median 6.1× FY 2025
P/FCF -18.7×
FY 2019: 6593×FY 2020: -11.8×FY 2021: -3.2×FY 2022: -0.9×FY 2023: -2.6×FY 2024: -5.3×FY 2025: -18.7×
FY 2019 5y median -3.2× FY 2025
EV/EBITDA -13.5×
FY 2019: 0.0×FY 2020: -3.6×FY 2021: -2.0×FY 2022: -0.4×FY 2023: -1.2×FY 2024: -4.1×FY 2025: -13.5×
FY 2019 5y median -2.0× FY 2025
EV/Sales 149×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 28.5×FY 2023: 7.9×FY 2024: 42.8×FY 2025: 149×
FY 2019 5y median 28.5× FY 2025
FCF Yield -5.3%
FY 2019: 0.0%FY 2020: -8.5%FY 2021: -31.6%FY 2022: -114.0%FY 2023: -39.1%FY 2024: -18.9%FY 2025: -5.3%
FY 2019 5y median -31.6% FY 2025

Profitability

Gross Margin 100.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.6%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 100.0%
FY 2019 5y median 100.0% FY 2025
Operating Margin -1130.6%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -5037.1%FY 2023: -468.8%FY 2024: -1097.6%FY 2025: -1130.6%
FY 2019 5y median -1097.6% FY 2025
Net Margin -1115.3%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -6635.3%FY 2023: -722.1%FY 2024: -1071.6%FY 2025: -1115.3%
FY 2019 5y median -1071.6% FY 2025
ROE -44.1%
FY 2019: 825.9%FY 2020: -17.1%FY 2021: -183.0%FY 2022: -17493.6%FY 2023: -148.9%FY 2024: -124.8%FY 2025: -44.1%
FY 2019 5y median -148.9% FY 2025
ROIC -34.9%
FY 2019: 929.2%FY 2020: -17.1%FY 2021: -106.8%FY 2022: -193.9%FY 2023: -52.6%FY 2024: -67.2%FY 2025: -34.9%
FY 2019 5y median -67.2% FY 2025
ROA -31.7%
FY 2019: -7433.3%FY 2020: -16.6%FY 2021: -81.6%FY 2022: -131.5%FY 2023: -64.6%FY 2024: -55.7%FY 2025: -31.7%
FY 2019 5y median -64.6% FY 2025

Growth (YoY)

Revenue 17.3%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 517.5%FY 2024: -46.1%FY 2025: 17.3%
FY 2019 FY 2025
Operating Income -20.8%
FY 2019: 0.0%FY 2020: -3756.7%FY 2021: -302.9%FY 2022: 27.3%FY 2023: 42.5%FY 2024: -26.3%FY 2025: -20.8%
FY 2019 FY 2025
EPS (diluted) 5.6%
FY 2019: 0.0%FY 2020: -11195.7%FY 2021: -36.5%FY 2022: 18.5%FY 2023: 74.6%FY 2024: 62.5%FY 2025: 5.6%
FY 2019 FY 2025
Free Cash Flow -15.0%
FY 2019: 0.0%FY 2020: -29589.6%FY 2021: -248.1%FY 2022: 18.3%FY 2023: 29.0%FY 2024: -1.5%FY 2025: -15.0%
FY 2019 FY 2025

Financial Health

Current Ratio 12.2×
FY 2019: 0.1×FY 2020: 36.2×FY 2021: 3.1×FY 2022: 1.5×FY 2023: 4.1×FY 2024: 5.4×FY 2025: 12.2×
FY 2019 5y median 4.1× FY 2025
Quick Ratio 12.2×
FY 2019: 0.1×FY 2020: 36.2×FY 2021: 3.1×FY 2022: 1.5×FY 2023: 4.1×FY 2024: 5.4×FY 2025: 12.2×
FY 2019 5y median 4.1× FY 2025
Debt / Equity 0.1×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.7×FY 2022: 63.1×FY 2023: 0.8×FY 2024: 0.9×FY 2025: 0.1×
FY 2019 5y median 0.8× FY 2025
Net Debt / EBITDA 2.8×
FY 2019: 0.0×FY 2020: 4.2×FY 2021: 0.5×FY 2022: 0.2×FY 2023: 0.8×FY 2024: 0.9×FY 2025: 2.8×
FY 2019 5y median 0.8× FY 2025
Interest Coverage -1754×
FY 2019: 0.0×FY 2020: -1536×FY 2021: -121×FY 2022: -33.2×FY 2023: -14.5×FY 2024: -897×FY 2025: -1754×
FY 2019 5y median -121× FY 2025

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31